The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Increased incidence of adverse events after concomitant hepatic arterial infusion plus systemic chemotherapy and bevacizumab for colorectal cancer with liver metastasis.
Sotaro Sadahiro
Disclosure not yet available
Toshiyuki Suzuki
Disclosure not yet available
Yuji Maeda
Disclosure not yet available
Akira Tanaka
Disclosure not yet available
Kazutake Okada
Disclosure not yet available
Kyoji Ogoshi
Disclosure not yet available
Akemi Kamijo
Disclosure not yet available